Publications:

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.

Oncotarget

Zhang, Lisa L; Zhang, Yaqin Y; Mehta, Amit A; Boufraqech, Myriem M; Davis, Sean S; Wang, Jing J; Tian, Ze Z; Yu, Zhiya Z; Boxer, Matthew B MB; Kiefer, Jeffrey A JA; Copland, John A JA; Smallridge, Robert C RC; Li, Zhuyin Z; Shen, Min M; Kebebew, Electron E

Publication Date: 2015-04-20

Variant appearance in text: PI3K: H419R

PubMed Link: 25940539

Variant Present in the following documents:

• Main text
• oncotarget-06-9073.pdf

View BVdb publication page